Ascend Laboratories
Ascend Laboratories is dedicated to producing high-quality, cost-effective generic medicines across various therapeutic areas. With a focus on safety, quality, and improving patient outcomes, Ascend leverages its world-class facilities and strategic partnerships to serve hospitals, pharmacies, and wholesalers in the USA. The company emphasizes innovation, regulatory compliance, and customer service, aiming to be a trusted provider in the healthcare industry.
Industries
Nr. of Employees
small (1-50)
Ascend Laboratories
135 Rt 202/206, Suite 15, Bedminster, NJ 07921 USA
Products
Extensive generic finished-dose pharmaceutical portfolio
A broad catalog of generic prescription products spanning multiple therapeutic classes and dosage forms (tablets, capsules, oral liquids and suspensions, topical creams and ointments, nasal sprays, granules), represented at NDC/SKU level for distribution.
Active pharmaceutical ingredients (APIs)
Manufacture and supply of APIs for internal finished-dose production and potential external partners, supporting vertical integration of the supply chain.
Extensive generic finished-dose pharmaceutical portfolio
A broad catalog of generic prescription products spanning multiple therapeutic classes and dosage forms (tablets, capsules, oral liquids and suspensions, topical creams and ointments, nasal sprays, granules), represented at NDC/SKU level for distribution.
Active pharmaceutical ingredients (APIs)
Manufacture and supply of APIs for internal finished-dose production and potential external partners, supporting vertical integration of the supply chain.
Services
Operational CRO capability to run bioequivalence and pharmacokinetic studies in a controlled clinical/hospital environment to generate regulatory-grade clinical data.
Manufacture of active pharmaceutical ingredients and finished-dose products across multiple facilities with segregation for specialized chemistries and adherence to cGMP.
Regulatory advisory and operational support including participation in risk evaluation and mitigation programs and systems for controlled products.
Sales, marketing and distribution operations to supply prescription products into hospital, retail and wholesale channels with national account management.
Provision of downloadable copay assistance materials and partnerships for mail-order fulfillment to support patients and caregivers.
Support for electronic data interchange and transaction processing with trading partners to streamline ordering and logistics.
Operational CRO capability to run bioequivalence and pharmacokinetic studies in a controlled clinical/hospital environment to generate regulatory-grade clinical data.
Manufacture of active pharmaceutical ingredients and finished-dose products across multiple facilities with segregation for specialized chemistries and adherence to cGMP.
Regulatory advisory and operational support including participation in risk evaluation and mitigation programs and systems for controlled products.
Sales, marketing and distribution operations to supply prescription products into hospital, retail and wholesale channels with national account management.
Provision of downloadable copay assistance materials and partnerships for mail-order fulfillment to support patients and caregivers.
Support for electronic data interchange and transaction processing with trading partners to streamline ordering and logistics.
Expertise Areas
- Generic drug development and ANDA regulatory submissions
- Bioequivalence and clinical pharmacokinetic execution
- cGMP finished-dose manufacturing
- API synthesis and upstream supply integration
Key Technologies
- cGMP manufacturing
- Bioequivalence clinical study execution
- API production and process chemistry
- Formulation for tablets, capsules, liquids, suspensions, topicals
News & Updates
Recall notice for Dabigatran, issued in March 2023.
Recall notice for Dabigatran, issued in March 2023.